171 related articles for article (PubMed ID: 29322459)
1. Application of Continuous Culture for Assessing Antibiotic Activity Against Mycobacterium tuberculosis.
Hendon-Dunn CL; Anwar S; Burton C; Bacon J
Methods Mol Biol; 2018; 1736():59-73. PubMed ID: 29322459
[TBL] [Abstract][Full Text] [Related]
2. The effect of growth rate on pyrazinamide activity in Mycobacterium tuberculosis - insights for early bactericidal activity?
Pullan ST; Allnutt JC; Devine R; Hatch KA; Jeeves RE; Hendon-Dunn CL; Marsh PD; Bacon J
BMC Infect Dis; 2016 May; 16():205. PubMed ID: 27184366
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium tuberculosis Is Resistant to Isoniazid at a Slow Growth Rate by Single Nucleotide Polymorphisms in katG Codon Ser315.
Jeeves RE; Marriott AA; Pullan ST; Hatch KA; Allnutt JC; Freire-Martin I; Hendon-Dunn CL; Watson R; Witney AA; Tyler RH; Arnold C; Marsh PD; McHugh TD; Bacon J
PLoS One; 2015; 10(9):e0138253. PubMed ID: 26382066
[TBL] [Abstract][Full Text] [Related]
4. A class of hydrazones are active against non-replicating Mycobacterium tuberculosis.
Bonnett SA; Dennison D; Files M; Bajpai A; Parish T
PLoS One; 2018; 13(10):e0198059. PubMed ID: 30332412
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium tuberculosis High-Throughput Screening.
White EL; Tower NA; Rasmussen L
Methods Mol Biol; 2016; 1439():181-95. PubMed ID: 27316996
[TBL] [Abstract][Full Text] [Related]
6. Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis.
Palomino JC; Martin A; Von Groll A; Portaels F
J Microbiol Methods; 2008 Oct; 75(2):161-6. PubMed ID: 18627779
[TBL] [Abstract][Full Text] [Related]
7. A Flow Cytometry Method for Assessing M. tuberculosis Responses to Antibiotics.
Hendon-Dunn CL; Thomas SR; Taylor SC; Bacon J
Methods Mol Biol; 2018; 1736():51-57. PubMed ID: 29322458
[TBL] [Abstract][Full Text] [Related]
8. Replication rates of Mycobacterium tuberculosis in human macrophages do not correlate with mycobacterial antibiotic susceptibility.
Raffetseder J; Pienaar E; Blomgran R; Eklund D; Patcha Brodin V; Andersson H; Welin A; Lerm M
PLoS One; 2014; 9(11):e112426. PubMed ID: 25386849
[TBL] [Abstract][Full Text] [Related]
9. [Clinical application of testing methods on acid-fast bacteria].
Ichiyama S; Suzuki K
Kekkaku; 2005 Feb; 80(2):95-111. PubMed ID: 15920982
[TBL] [Abstract][Full Text] [Related]
10. [The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections].
Wyplosz B; Truffot-Pernot C; Robert J; Jarlier V; Grosset J
Rev Mal Respir; 1997 Dec; 14 Suppl 5():S33-48. PubMed ID: 9496590
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
Khan A; Sarkar S; Sarkar D
Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
[TBL] [Abstract][Full Text] [Related]
12. The role of the time-kill kinetics assay as part of a preclinical modeling framework for assessing the activity of anti-tuberculosis drugs.
Bax HI; Bakker-Woudenberg IAJM; de Vogel CP; van der Meijden A; Verbon A; de Steenwinkel JEM
Tuberculosis (Edinb); 2017 Jul; 105():80-85. PubMed ID: 28610791
[TBL] [Abstract][Full Text] [Related]
13. [Determining dehydrogenase activity as a method of accelerated indication of the viability of Mycobacterium tuberculosis].
VishnevskiÄ BI; Manicheva OA
Probl Tuberk; 1992; (7-8):42-4. PubMed ID: 1488441
[TBL] [Abstract][Full Text] [Related]
14. [Genotypic and phenotypic methods for testing Mycobacterium tuberculosis sensitivity to antibiotics].
Melinte V
Bacteriol Virusol Parazitol Epidemiol; 2008; 53(2):67-88. PubMed ID: 19856846
[No Abstract] [Full Text] [Related]
15. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G
Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491
[No Abstract] [Full Text] [Related]
16. Determination of compound kill kinetics against Mycobacterium tuberculosis.
Early J; Alling T
Methods Mol Biol; 2015; 1285():269-79. PubMed ID: 25779322
[TBL] [Abstract][Full Text] [Related]
17. Activity of Moxifloxacin against
Louie A; Duncanson B; Myrick J; Maynard M; Nole J; Brown D; Schmidt S; Neely M; Scanga CA; Peloquin C; Drusano GL
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249693
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Mycobacteria Growth Indicator Tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis.
Palomino JC; Traore H; Fissette K; Portaels F
Int J Tuberc Lung Dis; 1999 Apr; 3(4):344-8. PubMed ID: 10206506
[TBL] [Abstract][Full Text] [Related]
19. Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems.
Piersimoni C; Olivieri A; Benacchio L; Scarparo C
J Clin Microbiol; 2006 Jan; 44(1):20-8. PubMed ID: 16390942
[No Abstract] [Full Text] [Related]
20. Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling.
Gumbo T; Louie A; Deziel MR; Parsons LM; Salfinger M; Drusano GL
J Infect Dis; 2004 Nov; 190(9):1642-51. PubMed ID: 15478070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]